Study S003209

A Randomised, Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570 Administered in Subjects With Overweight or Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06000891
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: DOUBLE
Status: TERMINATED
Enrollment: 84
Start: 2023-09-15
Primary completion: 2025-02-11
Lead sponsor: Zealand Pharma
Conditions: Safety and Tolerability
Interventions: DRUG:ZP7570; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: EUDRACT_NUMBER:2022-500614-26

Registered primary outcomes

Incidence of treatment emergent adverse events (TEAEs) [Day 1 to Day 127 in Part 1. Day 1 to Day 232 in Part 2]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.